Jiahui International Hospital in Shanghai has officially opened its cell therapy center. As the first internationally accredited hospital in Shanghai and one of the city's first high-level private medical insurance pilot institutions, Jiahui is receiving a growing number of overseas patients seeking innovative cell therapies such as CAR-T.
The center offers an end-to-end pathway: remote medical-record review, treatment planning, in-hospital therapy, and post-treatment follow-up. For international patients coming to China, this means access to internationally aligned cell therapy onshore, supported by direct-billing insurance and multilingual services.
MedBridge helps international patients connect with the Jiahui cell therapy center: remote pre-consultation, appointment coordination, travel and accompaniment arrangements, and a check of direct-billing coverage. Eligibility and suitability for cell therapy are determined by the center's physicians after reviewing the complete medical record.
(Source: Shangguan News, 2026-10-28)